ASIA News
LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
Cloudphysician targets to enter the United States, the Middle East, and Southeast Asia with its smart ICU and emergency department solutions.
Interestingly, young physicians see more risk to it than their senior counterparts.
Also, a gastric cancer detection tool in India has received a breakthrough designation from the US FDA.
The South Korean company now plans to expand the application of its AI to diagnose other medical conditions, including heart and neurological disorders.
Also, Lunit has completed its acquisition of breast screening AI company Volpara.
Sonio will remain an independent company following the acquisition.
They had been designated as innovative medical devices.
The wearable device enables scientists to hasten their analysis of skincare cosmetic products by up to 10 times.
They will also propose joint operating models for next-generation AI medical solutions.